go-v.orgdoi

Fesoterodine fumarate for the treatment of overactive bladder in the elderly – a review of the latest clinical data

Adrian Wagg · Clinical Investigation · 2012

  • DOI 10.4155/cli.12.68
  • Publisher OMICS Publishing Group
  • Type article
  • Issued 2012

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Clinical Investigation · OMICS Publishing Group · article · 2012

Abstract

Overactive bladder is a common and troublesome condition for many older people. Although the first-line treatment for the condition is with behavioral and lifestyle measures, many older people will require pharmacological therapy to successfully manage their condition. Fesoterodine, a relatively new antimuscarinic agent for the treatment of overactive bladder, has been extensively trialed in older people and is associated with a significant improvement in both disease related outcomes and in quality of life. Fesoterodine also appears to be well tolerated in this older group of patients. This review discusses the available evidence for fesoterodine in older people to date.

Open the resolved locator · 10.4155/cli.12.68

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 01:38 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.4155/cli.12.68
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.